Prdm2 — Pr Set Domain 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| PRDM2 Gene | |
|---|---|
| Full Name | PRDI-BF1 and RIZ Homology Domain Containing 2 |
| Chromosome | 1p36.21 |
| NCBI Gene ID | 7799 |
| OMIM | 605411 |
| Ensembl ID | ENSG00000116729 |
| UniProt ID | Q15691 |
| Description | Histone methyltransferase, tumor suppressor, transcriptional regulator |
| Associated Diseases | Schizophrenia, Bipolar Disorder, Breast Cancer, Prostate Cancer |
PRDM2 is a histone methyltransferase that functions as a transcriptional regulator and tumor suppressor. It catalyzes H3K9 methylation, which is associated with gene silencing. In the brain, PRDM2 regulates dopaminergic signaling and has been implicated in schizophrenia and bipolar disorder through altered expression of neurotransmitter-related genes. Reduced PRDM2 expression has been observed in brains of patients with neurodegenerative disorders.
The PRDM2 gene encodes a protein that plays important roles in Schizophrenia, Bipolar Disorder. This protein is involved in epigenetic regulation and transcriptional control mechanisms essential for normal neuronal function and survival.
PRDM2 is widely expressed in the human brain, with high expression in:
Expression is regulated during development and declines with age, which may contribute to age-related neurodegenerative processes.
The protein product of PRDM2 performs the following molecular functions:
Therapeutic targeting of PRDM2 may involve:
The study of Prdm2 — Pr Set Domain 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.